Nilotinib for Patients With Chronic Myeloid Leukemia in First Line and Any Subsequent Line
Condition: Chronic Myeloid Leukemia Intervention: Other: Nilotinib Sponsor: Novartis Pharmaceuticals Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials